Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters

The successful development of a chemoprophylaxis against SARS-CoV-2 could provide a tool for infection prevention that is implementable alongside vaccination programmes. Nafamostat is a serine protease inhibitor that inhibits SARS-CoV-2 entry in vitro, but it has not been characterised for chemoprop...

Descripción completa

Detalles Bibliográficos
Autores principales: Neary, Megan, Sharp, Joanne, Gallardo-Toledo, Eduardo, Herriott, Joanne, Kijak, Edyta, Bramwell, Chloe, Cox, Helen, Tatham, Lee, Box, Helen, Curley, Paul, Arshad, Usman, Rajoli, Rajith K. R., Pertinez, Henry, Valentijn, Anthony, Dhaliwal, Kevin, Mc Caughan, Frank, Hobson, James, Rannard, Steve, Kipar, Anja, Stewart, James P., Owen, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458615/
https://www.ncbi.nlm.nih.gov/pubmed/37632086
http://dx.doi.org/10.3390/v15081744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458615/
https://www.ncbi.nlm.nih.gov/pubmed/37632086
http://dx.doi.org/10.3390/v15081744

Ejemplares similares